PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.\', \'Brigham & Women\'s Hospital, Harvard Medical School, Boston, Massachusetts, United States of America.\', \'Department of Medicine, Division of Infectious Diseases, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.\', \'Asociación Civil Selva Amazónica, Iquitos, Peru.\', \'Division of AIDS, NIAID, NIH, Bethesda, Maryland, United States of America.\', \'Department of Surgery and Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, United States of America.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1371/journal.pmed.1003868
?:doi
?:hasPublicationType
?:journal
  • PLoS medicine
is ?:pmid of
?:pmid
?:pmid
  • 34871308
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 5.914
?:rankingScore_hIndex
  • 184
is ?:relation_isRelatedTo_publication of
?:title
  • Neutralizing antibody responses over time in demographically and clinically diverse individuals recovered from SARS-CoV-2 infection in the United States and Peru: A cohort study.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all